Phytoestrogen α-zearalanol improves vascular function in ovariectomized hyperhomocysteinemic rats

Atherosclerosis

Volumn 215, Issue 2, 2011, Pages 309-315

  Zhen, Pan Pan ^a   Duan, Jin Hong ^b   Zhao, Qian ^a   Hou, Dan Dan ^a   Wang, Hong Xia ^a   Hong, Ni ^b   Zhen, Hui Xian ^c   Wang, Wen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c Shanxi Polytechnic College   (China)

Author keywords

Zearalanol; 17 Estradiol; Hyperhomocysteinemia; Phytoestrogen; Vascular function

Indexed keywords

ACETYLCHOLINE; ALPHA ZERANOL; ENDOTHELIN 1; ESTRADIOL; HOMOCYSTEINE; METHIONINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ZERANOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; FEMALE; HYPERHOMOCYSTEINEMIA; MENOPAUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCANNING ELECTRON MICROSCOPY; THORACIC AORTA; TISSUE CHARACTERIZATION; VASCULAR DISEASE; WESTERN BLOTTING;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ENDOTHELIN-1; ESTRADIOL; FEMALE; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; METHIONINE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; OVARIECTOMY; PHENYLEPHRINE; PHYTOESTROGENS; RATS; RATS, WISTAR; ZERANOL;

EID: 79953065785     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.12.029     Document Type: Article

References (30)

1. Malinow M.R., Bostom A.G., Krauss R.M. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999, 99:178-182.
2. Kullo I.J., Ballantyne C.M. Conditional risk factors for atherosclerosis. Mayo Clin Proc 2005, 80:219-230.
3. Antoniades C., Antonopoulos A.S., Tousoulis D., et al. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 2009, 30:6-15.
4. Verhoeven M.O., van der Mooren M.J., Teerlink T., et al. The influence of physiological and surgical menopause on coronary heart disease risk markers. Menopause 2009, 16:37-49.
5. Schwertz D.W., Penckofer S. Sex differences and the effects of sex hormones on hemostasis and vascular reactivity. Heart Lung 2001, 30(401-426):427-428.
6. Gol M., Akan P., Dogan E., et al. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels. Maturitas 2006, 53:252-259.
7. Bonassi M.R., Chada B.E., Eduardo F.C., et al. Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance. Gynecol Endocrinol 2007, 23:619-624.
8. Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med 1991, 325:756-762.
9. Schindler A.E. Progestogen deficiency and endometrial cancer risk. Maturitas 2009, 62:334-337.
10. Opatrny L., Dell'Aniello S., Assouline S., Suissa S. Hormone replacement therapy use and variations in the risk of breast cancer. BJOG: Int J Obstet Gynaecol 2008, 115:169-175.
11. Kerlikowske K., Miglioretti D.L., Ballard-Barbash R., et al. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol 2003, 21:4314-4421.
12. Walker S.E., Adams M.R., Franke A.A., Register T.C. Effects of dietary soy protein on iliac and carotid artery atherosclerosis and gene expression in male monkeys. Atherosclerosis 2008, 196:106-113.
13. Duan J.H., Xu H.S., Dai S.L., et al. Phytoestrogen alpha-zearalanol inhibits homocysteine-induced endothelin-1 expression and oxidative stress in human umbilical vein endothelial cells. Atherosclerosis 2008, 197:549-555.
14. Duan J.H., Dai S.L., Fang C.X., et al. Phytoestrogen alpha-zearalanol antagonizes homocysteine-induced imbalance of nitric oxide/endothelin-1 and apoptosis in human umbilical vein endothelial cells. Cell Biochem Biophys 2006, 45:137-145.
15. Dai S., Duan J., Lu Y., et al. Phytoestrogen alpha-zearalanol inhibits atherogenesis and improves lipid profile in ovariectomized cholesterol-fed rabbits. Endocrine 2004, 25:121-129.
16. Dai S., Duan J., Lu Y., et al. Alpha-zearalanol, a phytoestrogen for cardiovascular therapy. Endocrine 2004, 25:117-119.
17. Celotto A.C., Fukada S.Y., Laurindo F., et al. Chronic hyperhomocysteinemia impairs vascular function in ovariectomized rat carotid arteries. Amino Acids 2010, 38:1515-1522.
18. Abraham D., Dashwood M. Endothelin role in vascular disease. Rheumatology 2008, 47(Suppl. 5):V23-V24.
19. Iglarz M., Clozel M. Mechanisms of ET-1-induced endothelial dysfunction. J Cardiovasc Pharmacol 2007, 50:621-628.
20. Amiri F., Virdis A., Neves M.F., et al. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 2004, 110:2233-2240.
21. Yen C.H., Lau Y.T. Vascular responses in male and female hypertensive rats with hyperhomocysteinemia. Hypertension 2002, 40:322-328.
22. Hansrani M., Stansby G. The use of an in vivo model to study the effects of hyperhomocysteinaemia on vascular function. J Surg Res 2008, 145:13-18.
23. de Andrade C.R., Fukada S.Y., Olivon V.C., et al. Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. Eur J Pharmacol 2006, 543:83-91.
24. Ungvari Z., Pacher P., Rischak K., et al. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 1999, 19:1899-1904.
25. Chen C., Conklin B.S., Ren Z., Zhong D.S. Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J Surg Res 2002, 102:22-30.
26. Wang S., Wright G., Harrah J., et al. Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism. Can J Physiol Pharmacol 2000, 78:500-506.
27. Jiang X., Yang F., Tan H., et al. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 2005, 25:2515-2521.
28. Upchurch G.R., Welch G.N., Fabian A.J., et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997, 272:17012-17017.
29. Drunat S., Moatti N., Paul J.L., et al. Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products. Eur J Biochem 2001, 268:5287-5294.
30. Ueland P.M. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995, 41:340-342.